http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2177619-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b1904ccfc0767286313efd8248055c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce10a70ba189b51fcb962373c43d9ea6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be88ba776d90fd6f8a50ba50c32c88b5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-70
filingDate 2000-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa42b82f2dd13f4498b3a48309095022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c76dccdaebfef35a41a932d400113c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07699f8853a480e7541e24ceab25e746
publicationDate 2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2177619-C1
titleOfInvention Method for predicting bone formation process development in treating the cases of false articulations
abstract FIELD: medicine. SUBSTANCE: method involves examining biochemical patient blood and urine properties. General alkaline phosphatase and its bone fraction activity before surgical intervention and Ca concentration, general hydroxyproline and creatinine is determined in daily urine portion and values are calculated like ratio K1 of general alkaline phosphatase activity to its bone fraction activity, Ca concentration K2 relative to 1 g of creatinine, general hydroxyproline concentration relative to 1 g of creatinine. All the values or at least one of them being K1 equal to or greater than 2, K2 greater than 340 mg/g and K3 equal to or greater than 54 mg/g, retarded bone formation process is to diagnosed. EFFECT: high accuracy and simplicity of the method. 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2526173-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2478973-C1
priorityDate 2000-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID882459
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40372
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43671
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID912538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558171
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID945041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6209972

Total number of triples: 40.